Further support came later when we administered HFCS to mice lacking KHK and found that it provided even more protection from obesity, fatty liver and insulin resistance, with about one-quarter of the effect from the glucose–insulin pathway [14]. The gene discussed is KHK; the disease is obesity due to melanocortin 4 receptor deficiency.